Difference between revisions of "Vermulst M"
From Bioblast
Beno Marija (talk | contribs) ย |
|||
(3 intermediate revisions by 3 users not shown) | |||
Line 17: | Line 17: | ||
|field of research=Basic | |field of research=Basic | ||
}} | }} | ||
== | == Participated at== | ||
* [[MiPNet19.06 | ::::* [[MiPNet19.06 IOC91 |IOC91 Philadelphia US]] |
Latest revision as of 17:06, 13 February 2018
Name | Vermulst Mark, |
---|---|
Institution | Center for Mitochondrial and Epigenomic Medicine (CMEM)
The Children's Hospital of Philadelphia - Research Institute Colket Translational Research Building |
Address | 3501 Civic Center Blvd, 19104 |
City | Philadelphia |
State/Province | Pennsylvania (PA) |
Country | USA |
[email protected] | |
Weblink | |
O2k-Network Lab | US PA Philadelphia Wallace DC |
Labels:
Field of research: Basic
Publications
Published | Reference | |
---|---|---|
McManus 2019 Cell Metab | 2019 | McManus MJ, Picard M, Chen HW, De Haas HJ, Potluri P, Leipzig J, Towheed A, Angelin A, Sengupta P, Morrow RM, Kauffman BA, Vermulst M, Narula J, Wallace DC (2019) Mitochondrial DNA variation dictates expressivity and progression of nuclear DNA mutations causing cardiomyopathy. Cell Metab 29:78-90. |